Mediterranean diet, obesity, and liver steatosis: Clinical evidence and implications for gastroenterology practice

Authors: Abenavoli, Ludovico; Scarlata, Giuseppe Guido Maria; Gambardella, Maria Luisa; Loricchio, Anna Giulia; Di Giovanni, Francesco; Bendriss, Ghizlane

Source journal: Best practice & research. Clinical gastroenterology (2026-09-01)

DOI: 10.1016/j.bpg.2026.102131

Abstract

Metabolic dysfunction-associated steatotic liver disease has become the most common chronic liver disease worldwide, closely linked to obesity, insulin resistance, and type 2 diabetes mellitus. Liver steatosis is now recognized as the hepatic manifestation of systemic metabolic dysfunction rather than an isolated liver condition, with fibrosis progression driving long-term outcomes. As pharmacologic options remain limited, lifestyle therapy is central to management. This narrative review summarizes current evidence on the Mediterranean diet as a therapeutic strategy for obesity-related liver steatosis. Mechanistic and clinical data show that this dietary pattern targets key drivers of hepatic fat accumulation and cardiometabolic risk. Observational studies and randomized clinical trials demonstrate improvements in liver fat and metabolic parameters, often beyond those achieved with weight loss alone. The Mediterranean diet is safe, sustainable, and applicable in gastroenterology practice. Future priorities include standardized adherence metrics, longer outcome-driven trials, and precision nutrition approaches integrating metabolic and gut microbiota profiles.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.